| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technical Officer | Chief Technology Officer
1 company
Tsai Philip is a Chief Technical Officer at IMNM. Recent filings cover 3 purchases and 0 sales.
Our model assigns Tsai Philip a strong insider score of 76/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +98.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | IMNM Immunome Inc. | Chief Technical Officer | Buy | 10,000 | $20.49 | $204,900.00 | +30.0% | -2.8% | - | |
| Mar 24, 2025 | IMNM Immunome Inc. | Chief Technology Officer | Buy | 12,300 | $8.42 | $103,566.00 | +58.6% | +7.2% | +148.0% | |
| Nov 21, 2024 | IMNM Immunome Inc. | Chief Technology Officer | Buy | 21,000 | $9.43 | $198,030.00 | New | +5.1% | +96.7% |